Journal Mobile Options
Table of Contents
Vol. 44, No. 4, 1998
Issue release date: July–August 1998
Gerontology 1998;44:217–221
(DOI:10.1159/000022013)

Effects of Central Nervous System Polypharmacy on Falls Liability in Community-Dwelling Elderly

Weiner D.K. · Hanlon J.T. · Studenski S.A.
a Center for the Study of Aging and Human Development, b Department of Medicine and c Duke University Arthritis Center, Duke University Medical Center, and d Geriatrics Research, Education and Clinical Center, Durham Veterans Affairs Medical Center, Durham, N.C., and e School of Pharmacy, University of North Carolina at Chapel Hill, N.C., and f Department of Medicine, and Center on Aging, University of Kansas Medical Center, Kansas City, Kans., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: While central nervous system (CNS) active medications such as psychotropics and narcotic analgesics have been implicated in contributing to falls in older adults, the combined effect of multiple CNS-active medications has not been investigated. The purpose of this study was to examine the influence, in community-dwelling elderly, of (1) taking multiple CNS-active medications on fall liability and (2) individual classes of CNS-active medications (using discrete drug classification) on the risk of falls after controlling for important confounders – age, mobility, cognition and depression. Methods: 305 community-dwelling male veterans (age: 70–104) were screened at study entry for mobility, cognition and depression. CNS-active medications were categorized as benzodiazepines, other sedative-hypnotics, neuroleptics, tricyclic antidepressants, and opioid analgesics. Subjects were prospectively followed for 6 months to monitor falls; at the end of this time period, subjects were classified as fallers (at least one fall) or nonfallers. The relationship between CNS-active drug use and falls was examined using multivariable analyses. Results: The risk of falls was significantly greater in CNS-active medication users as compared with nonusers. Adjusted odds ratio for one CNS-active drug was 1.54 (95% confidence interval 1.07–2.22) and for two or more agents 2.37 (95% confidence interval 1.14–4.94). Conclusions: In community-dwelling elderly, the use of multiple CNS-active medications is associated with enhanced falls liability, over and above the use of one CNS-active drug alone. This apparent dose-response relationship provides support for causality.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Fife D, Barancik JI, Chatterjee MS: Northeastern Ohio Trauma Study II: Injury rates by age, sex and cause. Am J Publ Health 1984;74:473–478.

    External Resources

  2. Baker SP, Harvey SH: Fall injury in the elderly. Clin Geriatr Med 1985;1:501–507.
  3. Kennedy TE, Coppard LC (eds): The prevention of falls in later life. Dan Med Bull 1987;34(suppl 4):1.
  4. Campbell AJ, Reinkein J, Allan BC, Martinez GS: Falls in old age: A study of frequency and related clinical factors. Age Ageing 1981;10:264–270.
  5. Tinetti ME, Speechley M, Ginter SF: Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701–1707.
  6. Campbell AJ: Drug treatment as a cause of falls in old age – A review of the offending agents. Drugs Aging 1991;1:289–302.
  7. Macdonald JB: The role of drugs in falls in the elderly. Clin Geriatr Med 1985;1:621–636.
  8. Campbell AJ, Spears GF, Borrie MJ: Examination by logistic regression modelling of the variables which increase the relative risk of elderly women falling compared to elderly men. J Clin Epidemiol 1990;43:1415–1420.
  9. Sorock GS, Shimkin EE: Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Arch Intern Med 1988;148:2441–2444.
  10. Nevitt MC, Cummings SR, Hudes ES: Risk factors for injurious falls: A prospective study. J Gerontol 1991;46:M164–M170.

    External Resources

  11. Nevitt MC, Cummings SR, Kidd S, Black D: Risk factors for recurrent nonsyncopal falls – A prospective study. JAMA 1989;261:2663–2668.
  12. Shorr RI, Griffin MR, Daugherty JR, Ray WA: Opioid analgesics and the risk of hip fracture in the elderly: Codeine and propoxyphene. J Gerontol 1992;47:M111–M115.

    External Resources

  13. Vetter NJ, Ford D: Anxiety and depression scores in elderly fallers. Int J Geriatr Psychiatry 1989;4:159–163.
  14. Sehested P, Severin-Nielsen T: Falls by hospitalised elderly patients: Causes, prevention. Geriatrics 1977;32:101–108.
  15. Prudham D, Evans JG: Factors associated with falls in the elderly: A community study. Age Ageing 1981;10:141–146.
  16. Davie JW, Blumenthal MD, Robinson-Hawkins S: A model of risk of falling for psychogeriatric patients. Arch Gen Psychiatry 1981;38:463–467.

    External Resources

  17. Tinetti ME, Williams TF, Mayewski R: Falls risk index for elderly patients based on number of chronic disabilities. Am J Med 1986;80:429–434.
  18. Tinker GM: Accidents in a geriatric department. Age Ageing 1979;8:196–198.

    External Resources

  19. Wild D, Nayak USL, Isaacs B: How dangerous are falls in old people at home? Br Med J 1981;282:266–268.
  20. Wickham C, Cooper C, Margetts BM, Barker DJP: Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing 1989;18:47–51.

    External Resources

  21. Sobel KG, McCart GM: Drug use and accidental falls in an intermediate care facility. Drug Intell Clin Pharm 1983;17:539–542.

    External Resources

  22. Morse JM, Prowse MD, Morrow N, Federspeil G: A retrospective analysis of patient falls. Can J Publ Health 1985;76:116–118.
  23. Blake AJ, Morgan K, Bendall MJ, Dallosso H, Ebrahim SB, Arie TH, Fentem PH, Bassey EJ: Falls by elderly people at home: Prevalence and associated factors. Age Ageing 1988;17:365–372.
  24. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton J: Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987;316:363–369.
  25. Ray WA, Griffin MR, Downey W: Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989;262:3303–3307.
  26. Lipsitz LA, Jonsson PV, Kelley MM, Koestner JS: Causes and correlates of recurrent falls in ambulatory frail elderly. J Gerontol 1991;46:M114–M122.

    External Resources

  27. Grisso JA, Kelsey JL, Strom BL, Chiu GY, Maislin G, O’Brien LA, Hoffman S, Kaplan F, and the Northeast Hip Fracture Study Group: Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991;324:1326–1331.
  28. Granek E, Baker SP, Abbey H, Robinson E, Myers AH, Samkoff JS, Klein LE: Medications and diagnoses in relation in falls in a long-term care facility. J Am Geriatr Soc 1987;35:503–511.

    External Resources

  29. Cumming RG, Miller JP, Kelsey JL, Davis P, Arfken CL, Birge SJ, Peck WA: Medications and multiple falls in elderly people: The St. Louis OASIS study. Age Ageing 1991;20:455–461.
  30. Kerman M, Mulvihill M: The role of medication in falls among the elderly in a long-term care facility. Mt Sinai J Med 1990;57:343–347.
  31. Trewin VF, Lawrence CJ, Veitch GBA: An investigation of the association of benzodiazepines and other hypnotics with the incidence of falls in the elderly. J Clin Pharmacol Ther 1992;17:129–133.
  32. Studenski S, Duncan PW, Chandler J, Samsa G, Prescott B, Hogue C, Bearon LB: Predicting falls: The role of mobility and nonphysical factors. J Am Geriatr Soc 1994;42:297–302.
  33. Folstein MF, Folstein S, McHugh PR: Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  34. Koenig HG, Cohen HJ, Blazer DG, Meador KG, Westlund R: A brief depression scale for use in the medically ill. Int J Psychiatry Med 1992;22:183–195.
  35. Yesavage JA, Rink TL, Rose TL, et al: Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1983;17:37–49.
  36. Duke Depression Evaluation Schedule for the Elderly, Center for the Study of Depression in Later Life, Department of Psychiatry, Duke University Medical Center, Durham, North Carolina, 1988.
  37. Veterans Affairs Medication Classification System; in: United States Pharmacopeia Dispensing Information (USPDI), ed 10. Appendix VI, 1990, p 2925–2960.
  38. Hanlon JT, Fillenbaum GG, Burchett B, Wall WE, Service C, Blazer DG, George LK: Drug-use patterns among black and nonblack community-dwelling elderly. Ann Pharmacother 1992;26:679–685.
  39. Hartzema AG, Porta MS, Tilson HH (eds): Pharmacoepidemiology: An Introduction, ed 2. Cincinatti, Whitney, 1991, p 419.
  40. Kleinbaum DG, Kupper LL, Muller KE: Applied Regression Analysis and Other Multivariable Methods, ed 2. Boston, PWS-Kent, 1988.
  41. Fillenbaum GG, Hanlon JT, Corder EH, Ziqubu-Page T, Wall WE, Brock D: Prescription and nonprescription drug use among black and white community-residing elderly. Am J Publ Health 1993;83:1577–1582.
  42. Robbins AS, Rubenstein LZ, Josephson KR, Schulman BL, Osterweil D, Fine G: Predictors of falls among elderly people – Results of two population-based studies. Arch Intern Med 1989;149:1628–1633.
  43. Hanlon JT, Cutson T, Ruby CM: Drug-related falls in the elderly. Top Geriatr Rehabil 1996;11:38–54.
  44. Thapa PB, Gideon P, Fought RL, Ray WA: Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents. Am J Epidemiol 1994;142:202–211.
  45. King MB, Tinetti ME: Falls in community-dwelling older persons. J Am Geriatr Soc 1995;43:1146–1154.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50